We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600547:SSEShandong Gold Mining Co., Ltd. Class A Analysis

Data as of 2026-07-23 - not real-time

CN¥27.42

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shandong Gold Mining trades at 27.42 CNY, barely below its DCF‑derived fair value of 27.70 CNY, suggesting a fairly priced entry point. The stock sits under its 20‑day (24.76) and 50‑day (27.11) moving averages but above the 200‑day SMA (37.31), indicating short‑term weakness within a long‑term bearish backdrop. Technical momentum is mixed: RSI at 57.6 signals neither overbought nor oversold conditions, while the MACD line has turned bullish above its signal (histogram +0.55). Volatility is high at >60% over the past 30 days, yet the computed beta of 0.07 points to low market‑wide correlation. Fundamentally, revenue surged 25% YoY, profit margins are modest (4.7%) but improving, and forward EPS of 1.99 drives the forward PE down to 13.8×. The balance sheet shows a high debt‑to‑equity ratio (~100%) but ample cash and positive free cash flow, supporting the 1.29% dividend with a payout ratio of just 31%.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Bullish MACD crossover despite broader bearish trend
  • Price near DCF fair value offering limited downside
  • Stable trading volume and low beta reducing market shock

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 25% revenue growth and improving forward EPS
  • Forward PE of 13.8× indicating attractive valuation relative to earnings outlook
  • Sustainable dividend supported by positive free cash flow

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • High debt‑to‑equity ratio introduces balance‑sheet risk over time
  • Gold price exposure and basic materials sector volatility
  • Consistent dividend yield and solid ROE (~12%) provide steady return

Key Metrics & Analysis

Financial Health

Revenue Growth25.40%
Profit Margin4.65%
P/E Ratio26.6
ROE12.06%
ROA5.71%
Debt/Equity100.47
P/B Ratio3.9
Op. Cash FlowCN¥25.1B
Free Cash FlowCN¥4.9B

Technical Analysis

TrendBearish
RSI57.6
SupportCN¥22.55
ResistanceCN¥28.09
MA 20CN¥24.76
MA 50CN¥27.11
MA 200CN¥37.31
MACDBullish
VolumeStable
Fear & Greed Index88.04

Valuation

Fair ValueCN¥27.70
GradeFair
TypeBlend
Dividend Yield1.29%

Risk Assessment

Beta0.07
Volatility60.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.